Log in
Enquire now
Riken Genesis Co., Ltd.

Riken Genesis Co., Ltd.

Riken Genesis Company Limited is a company that has garnered experience in genetic analysis.

OverviewStructured DataIssuesContributors

Contents

rikengenesis.jp
rikengenesis.jp...ny.html
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
‌
Medical'S
Drug discovery
Drug discovery
Location
Yokohama
Yokohama
Tokyo
Tokyo
B2X
B2B
B2B
Legal Name
Riken Genesis Co., Ltd.
Legal classification
Limited company
Limited company
Number of Employees (Ranges)
51 – 200
Full Address
Riken Yokohama InstituteEast Research Bldg 3F1-7-22 Suehiro-choTsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan
Investors
Sysmex Corporation
Sysmex Corporation
Toppan Printing
Toppan Printing
0
Total Funding Amount (USD)
2,753,632
Latest Funding Round Date
June 2014
Latest Funding Type
‌
Venture round
Country
Japan
Japan

Other attributes

Company Operating Status
Active

Riken Genesis Company Limited is a company that has garnered experience in genetic analysis. Riken Genesis is engaged in four businesses such as pharmaceutical development support, gene contract analysis, and reagents and diagnostic reagents.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Riken Genesis Co., Ltd.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.